Abstract
The antiepileptic drugs sodium valproate (VPA) and lamotrigine (LTG) are increasingly used in combination in patients in whom monotherapy has failed to control seizures. Although these drugs are known to interact pharmacokinetically, several authors have proposed a pharmacodynamic interaction between the two. In order to investigate this we have studied the effects of combined treatment with LTG and VPA on basal and stimulated extracellular aspartate (ASP), glutamate (GLU), taurine (TAU), gamma amino butyric acid (GABA), 5-hydroxytryptamine (5-HT) and dopamine (DA) release in the hippocampus of freely moving rats using microdialysis. Additionally, we measured the possible effect of VPA on LTG in plasma, whole brain and dialysates. Neither LTG (10 mg/kg) nor VPA (300 mg/kg) given alone significantly altered basal levels of ASP, GLU or TAU. When given together, however, the two drugs significantly reduced extracellular ASP and GLU while increasing TAU levels. In the case of GABA, LTG was without effect on basal levels of the transmitter, but these increased following VPA and this persisted with both drugs. When transmitter release was stimulated by 50 μM veratridine, marked increases in the release of all amino acids occurred and this was decreased by LTG in all cases. VPA alone only altered GABA release, increasing it by approximately the same extent as basal GABA. For all of the amino acids studied, however, VPA reversed the decreases in release seen after LTG. VPA and LTG increased and decreased respectively basal 5-HT and DA. When given together the increase in extracellular 5-HT was greatly prolonged, but no effect on DA release was seen. When 5-HT release was evoked by veratridine this was increased by VPA and no other treatment. With DA, however, neither drug alone altered evoked release, but the two combined led to a marked increase. Co-administration of VPA with LTG showed no significant effect of this combination on LTG in any of the three compartments studied indicating that in this case a significant pharmacokinetic contribution to our findings is unlikely, which suggests that there is a probable pharmacodynamic interaction of the two drugs.
Similar content being viewed by others
References
Afanas’ev I, Kudrin V, Rayevsky KS, Varga V, Saransaari P, Oja SS (1999) Lamotrigine and carbamazepine affect differentially the release of d-[3H]aspartate from mouse cerebral cortical slices. Neurochem Res 24:1153–1159
Ahmad S, Fowler LJ, Leach MJ, Whitton PS (1995) Lamotrigine alters veratridine but not high K+ evoked amino acid release in the ventral hippocampus of the rat in vivo. Br Pharmacol Soc 115:116P
Ahmad S, Fowler LJ, Whitton PS (2004a) Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. Br J Pharmacol 142:136–142
Ahmad S, Fowler LJ, Whitton PS (2004b) Effect of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats. Brain Res 1029:41–47
Bazil CW (2002) New antiepileptic drugs. Neurology 8:71–81
Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine and their metabolites in rat brain: an in vivo microdialysis study. J Neurochem 59:1702–1706
Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1994) The effect of isonicotinic acid hydrazide on extracellular amino acids and convulsions in the rat: reversal of neurochemical and behavioural deficits by sodium valproate. J Neurochem 63:2197–2201
Braga MF, Aroniadou-Anderjaska V, Post RM, Li H (2002) Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders. Neuropharmacology 42:522–529
Cuadrado A, De La Cuevas I, Valdizan EM, Armijo JA (2002) Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice. Eur J Pharmacol 453:43–52
Cuadrado A, Bravo J, Armijo JA (2003) Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice. Eur J Pharmacol 465:43–52
Cunningham MO, Jones RSG (2000) The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vivo. Neuropharmacology 39:2139–2141
Dailey JW, Yan Q-S, Adams-Curtis L, Ryu JR, Ko KH, Mishra PK, Jobe PC (1996) Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci 58:259–266
Deckers CLP, Genton P, Sills GJ, Schmidt D (2003) Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res 53:1–17
Della Paschoa OE, Kruk MR, Hamstra R, Voskuyl RA, Danhof M (1998a) Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern. Br J Pharmacol 125:997–1004
Della Paschoa OE, Voskuyl RA, Danhof M (1998b) Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate. Br J Pharmacol 125:1610–1616
De Sarro G, Nava F, Aguglia U, De Sarro A (1996) Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Neuropharmacology 35:153–158
Esclapez M, Hirsch JC, Ben-Ari Y, Bernard C (1999) Newly formed excitatory pathways for hyperexcitability in experimental temporal lobe epilepsy. J Comp Neurol 408:449–460
Ferraro G, Vella N, Sardo P, Caravaglios G, Sabatino M, LaGrutta V (1991) Dopaminergic control of feline hippocampal epilepsy: a nigrohippocampal pathway. Neurosci Lett 123:41–44
Ferrie CD, Panayiotopoulos CP (1994) Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy. Seizure 3:157–159
Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP (1995) Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 91:200–202
Gervasi N, Monnier Z, Vinvent P, Paupardin-Tritsch D, Hughes SW, Crunelli V, Leresche N (2003) Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures. J Neurosci 23:11469–11478
Gidal BE, Anderson GE, Rutecki PR, Shaw R, Lanning A (2000) Lack of an effect of valproate on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epilepsy Res 42:22–31
Ichikawa J, Meltzer HY (1999) Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation. Eur J Pharmacol 380:R1–R3
Kanner AM, Frey M (2000) Adding valproate to lamotrigine: a study of their pharmacokinetic interaction. Neurology 22:588–591
Kimura M, Tanaka N, Kimura Y, Miyake K, Kitaura T, Fukuchi H (1992) Pharmacokinetic interaction of zonisamide in rats. J Pharmacobiodyn 15:631–639
Kwan P, Sills GJ, Brodie MJ (2001) The mechanism of action of commonly used antiepileptic drugs. Pharmacol Ther 90:21–34
Lees G, Leach MJ (1993) Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamactil) using primary neurological cultures from rat cortex. Brain Res 612:190–199
Levy RH, Bourgeois BFD (1997) Drug–drug interactions. In: Engel J, Pedley TA (eds) Epilepsy: a comprehensive textbook. Lippincott-Raven, Philadelphia, pp 1175–1179
Lolin YI, Ratnaraj N, Hjelm, M, Patsalos PN (1994) Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin. Epilepsy Res 19:99–110
Morris RG, Black AB, Lam E, Westley IS (2000) Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage? Ther Drug Monit 22:656–660
Okada M, Hirano T, Mizuno K, Chiba T, Kawata Y, Kiryu K, Wada K, Tasaki H, Kaneko S (1997) Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus. Epilepsy Res 28:143–153
Panayiotopoulos GP, Ferrie CD, Knott C, Robinson RO (1993) Interaction of lamotrigine with sodium valproate. Lancet 341:445
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic, New York
Petroff OAC, Rothmann DL, Behar KL, Hyder F, Mattson RH (1999) Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure 8:120–127
Pisani F, Di Perri R, Perucca E, Richens A (1993) Interaction of lamotrigine with sodium valproate. Lancet 341:1224
Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A (1999) The efficacy of valproate–lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40:1141–1146
Reife RA (1998) Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs. Adv Neurol 76:95–103
Rowley HL, Marsden CA, Martin KF (1995) Differential effects of phenytoin and sodium valproate on seizure-induced changes in gamma-aminobutyric acid and glutamate release in vivo. Eur J Pharmacol 294:541–546
Smolders I, Van Belle K, Ebinge G, Michotte Y (1997) Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. Eur J Pharmacol 319:21–29
Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, Fazilat S, Kopylev L, Herscovitch P, Ecklemann WC, Theodore WH (2003) PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60:749–756
Waldmeier PC, Baumann PA, Wick P, Feldtrauer JJ, Stierlin C, Scmutz M (1995) Similar potency of carbamazepine, oxcarbazepine and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907–1913
Waldmeier PC, Martin P, Stocklin K, Portet C, Scmutz M (1996) Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn-Schmiedebergs Arch Pharmacol 354:164–172
Wang SJ, Sibra TS, Gean PW (2001) Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuroreport 12:2255–2258
Whitton PS, Fowler LJ (1991) The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo. Eur J Pharmacol 200:167–169
Whitton PS, Oreskovic D, Jernej B, Bulat M (1984) Antiepileptic di-n-propylacetamide and di-n-propylacetic acid increase the noradrenaline turnover in the brain. Period Biol 86:231–234
Whitton PS, Biggs CS, Pearce BR, Fowler LJ (1992) MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum. J Neurochem 58:1573–1575
Xie X, Dale TJ, John VH, Cater HL, Peakman TC, Clare JJ (2001) Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line. Pflugers Arch 441:425–433
Yerby MS (2003) Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 61:S23–S36
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmad, S., Fowler, L.J. & Whitton, P.S. Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats. Naunyn-Schmiedeberg's Arch Pharmacol 371, 1–8 (2005). https://doi.org/10.1007/s00210-004-1008-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-004-1008-4